Potential candidates include specific oxidative stress markers, genetic polymorphisms in antioxidant enzymes, or epigenetic modifications [147]
John Carroll, President of Connected Commerce for Acosta Group, said forward-thinking brands are already dialing up their response
Visceral fat correlates more strongly with cardiovascular disease risk, type 2 diabetes development, and mortality than subcutaneous fat
Inadequate protein creates substrate limitation for both
In March 2024 , the FDA approved Wegovy for another purpose: to reduce the risk of cardiovascular death, heart attack, or stroke in adults with existing heart disease and either obesity or overweight
Allergic reactions (though rare, they may include rash, itching, or difficulty breathing)